Stefaan W. Van Gool is Medical Director of the Praxis für Immunonkologie & Translationale Medizin, Immun-Onkologisches Zentrum Koln. He is also the Qualified Person and the Medical Responsible Person in the Good Manufacturing Practice Laboratories of the Immun-Onkologisches Zentrum Koln. He trained as pediatric neuro-oncologist in Leuven (Belgium) and Munster (Germany), got his PhD degree in immunology and became Clinical Head of pediatric neuro-oncology and full professor at the KU Leuven. Till 2022 he published 167 peer-reviewed papers. For his work, he received several national and international awards.

Dr. Irving H. Smith serves as the CSU Faculty Athletics Representative, Chair of the CSU Department of Health Sciences, and Advisor to the Fellowship of Christian Athletes. Dr. Smith was recently named President of the Mid-Eastern Athletic Conference (MEAC) for the 2018-2020 term and Chair of the MEAC Faculty Athletic Representatives. Dr. Smith retired in 2013 after 45 years of public service to become Chair of Health Sciences at Coppin State. He began at Coppin in 2008 as a faculty member in the Sport Management program. Before retirement, he taught, trained, and certified more than 65,000 coaches of all sports over a 20-year period. He also served as a national surrogate speaker for former US President Bill Clinton’s healthcare initiative, and prior to that served on a panel of presenters as part of the White House Conference on Aging, speaking on the benefits to aging individuals of lifetime sports participation. He is an internationally recognized speaker/presenter and published academic author on sports and health related topics including the health and wellness benefits of lifetime sports participation. Some of that research was published in the Journal of Sports Science and he presented those findings at the International Health Conference in London, England. Smith was also part of a research team that conducted health disparities research in Honduras. He published the findings of that research in the International Journal of Health Sciences and presented those findings at the International Conference on Public Health in Athens, Greece. Other research includes best practices for mentoring student-athletes that was published in the Journal of Physical Education and Sports Management as well as research on gesticulation that was published in the International Journal of Linguistics and Communication. Prior to Coppin, Dr. Smith taught Sports Psychology and Health Psychology at Johns Hopkins University for five years and at the American School of Professional Psychology at Argosy University. A student first/student centered professor, in a University-wide survey of faculty, staff, and students, Dr. Smith was voted one of that institution’s “most inspiring” professors, more than a year after his departure. For more than 10 years, Dr. Smith served as the Regional Director of Leisure and Aging for the National Recreation and Park Association representing Maryland, Pennsylvania, Delaware, New Jersey and New York.

Dr. Constantinos Sioutas, Sc.D., is the first holder of the Fred Champion Professorship in Civil and Environmental Engineering at the University of Southern California (USC), starting in 2006, and the director of the University of Southern California Aerosol Laboratory at the department of Civil and Environmental Engineering Utilizing an integrated approach in his research, over the past twenty-five years Dr. Sioutas has generated a well-publicized body of work demonstrating the significant effects that particulate air pollution has on human health and the environment. According to the World Health Organization (WHO), outdoor particulate air pollution is estimated to cause roughly 4 million premature deaths worldwide, making it the sixth non-injury related cause of mortality globally. Dr. Siouta's research has focused on investigations of the underlying mechanisms that produce the health effects associated with exposure to particulate air pollutants that are generated by a variety of combustion sources, most notably traffic (including light- and heavy-duty vehicles, natural gas buses and biodiesel vehicles), harbor and airport operations and power plants, as well as the degree to which photochemical processing of these emissions alters these particle's physical, chemical and toxicological properties. A unique aspect of Dr. Siouta's research has been his use of feedback from ongoing biological and toxicological in vivo, in vitro, epidemiological and risk assessment research studies that use combustion-generated aerosols in order to identify strategies that would reduce health risks. Such information is crucial in implementing effective control strategies and environmental regulations that would reduce public exposure to toxic particulate pollutants and, the enforcement of which, in fact, has led to improvements in air quality. His research activities have been recognized internationally, resulting in a number of collaborations studying the characterization as well as the health and environmental effects of particulate air pollution across the globe. The complex and dynamic multi-pollutant atmosphere of Southern California, which is comprised of particulate matter (PM) of various sizes and chemical constituents (i.e., vapor-phase semi-volatile organic compounds (SVOCs) that are in equilibrium with their particle phase, gas-phase constituents including volatile organic compounds (VOCs) and other gaseous co-pollutants), has been the focal point of Dr Siouta's research. These anthropogenic pollutants, emitted by the abundant traffic sources of the Los Angeles basin are in dynamic equilibrium, and their chemical composition as well as partitioning between the PM and vapor phases vary according to sources, season and temperature, as well as the atmospheric transformations that take place over distance and time. In collaboration with his colleagues at University of California Los Angeles, Dr. Sioutas and his group at USC were the first to study the formation and dynamics of traffic-generated particulate air pollutants near freeways, demonstrating the more than ten-fold increase in exposure to toxic pollutants near freeways and busy thoroughfares. These studies have produced highly cited publications (including the Hagen-Smit award of Atmospheric Environment for seminal paper in 2011) and have been used as a criterion for placing schools near roadways as part of the state of California Senate Bill 25 (SB25). Moreover these studies served as the impetus for the design of numerous “near-roadway” studies, first in the U.S. and more recently in Europe and Asia, investigating the association between elevated exposures and adverse health effects in humans who live in the proximity of roadways and busy thoroughfares. Dr. Sioutas has also developed state-of-the-art particle concentrator technologies that allow for the assessment of the relative toxicity of particulate pollution from a variety of sources and formation mechanisms which use, for the first time in the literature, realistic atmospheres in in vivo and in vitro studies undertaken by multimillion-dollar research centers funded by the U.S. EPA, NIH and CARB in Southern California. Additionally, Dr. Sioutas has led the design and development of innovative and effective particulate sampling technologies that make it possible to characterize the chemical composition of PM in short time intervals (i.e. hourly compared to the more traditional 24-hr based data used in air quality monitoring). Such information is vital, not only for determining the diurnal profiles of toxic species in PM, but also in the identification of their sources. Dr. Sioutas has also developed personal monitoring devices that made it possible for the first time to quantitatively characterize ultrafine PM (particles below roughly 0.2 micrometers (a more toxic sub range of PM2.5)) that have been used by epidemiologists in Sothern California to measure children's exposures to air pollutants in the Los Angeles basin and to determine how such exposure relates to lung growth and the exacerbation of early asthma. Several of these personal monitoring technologies are also being used by agencies such as the U.S. EPA, as well as a host of international institutes in Europe and Asia. These technologies, combined with novel source apportionment techniques, have also been instrumental in a major NIH funded panel study that seeks to demonstrate for the first time stronger associations between systemic inflammation and primary than secondary PM in elderly populations in the Los Angeles Basin. The same study also demonstrated stronger association between respiratory inflammation and secondary organic aerosols than primary PM, thereby establishing for the first time a clear distinction of the effects of primary versus secondary emissions in the Los Angeles basin. These findings are critical in the promulgation of air quality control strategies as they underscore for the first time differential health outcomes associated with primary versus secondary PM. During his 27-year faculty career, Dr. Sioutas has directed, as either a Principal or Co-Principal Investigator, over 70 extramural and highly multi-disciplinary research grants exceeding $50 million in total, with his share at USC at $24 million. He has authored over 390 peer-reviewed journal publications and five book chapters and holds thirteen U.S. patents in the development of instrumentation for aerosol measurement and emissions control. His published work has received over 32,000 citations according to the ISI Web of Science. He has advised twenty-six Ph.D. students and has mentored twenty-three postdoctoral fellows at USC. Results from his publications have been used by the U.S. Environmental Protection Agency (EPA) in their National Air Quality Criteria document in promulgating stricter and more protective air quality standards in the U.S. as well as by the state of California in the promulgation of Senate Bill 25 for protecting the health of children.

Mustafa Younis is an internationally recognized scholar at Jackson State University, Mississippi, USA. Dr. Younis served as a member of the Executive Committee of the International Society for Research of Healthcare Financial Management. Dr. Younis has authored and published over 200 articles, abstracts and presentations in refereed journals and meetings, and has presented at national and international conferences. Dr. Younis’ coauthored articles appeared in leading journals such as “Nature”, “the Lancet” and “JAMA” and European Journal of Health Economics.Dr. Younis has administrative experience as Chair of the Department of Health Policy and Management at Florida International University (FL, USA), where he led the accreditation efforts for the Healthcare Management Program. Dr. Younis has a history of playing visible roles on the editorial boards of journals as Chief Editor, Guest Editor and Editorial board member of leading journals, such as JHCF, Inquiry, JHHSA, JPBAFM, EJEPH. Dr. Younis is a frequent speaker for both academic and professional audiences. His talks often feature his latest research and work in progress, as well as cross-industry trends and strategy implications. He has provided workshops and presentations for world-wide organizations. His research and findings apply to for-profit, non-profit, and government settings. Dr. Younis has consulted with several organizations on healthcare finance, and economics. Dr. Younis is often invited to speak about the challenges in the healthcare industry and other related topics to health economics, finance, and research. He has presented topics, such as, healthcare reform, ownership structure, profitability, unit cost, payment system and efficiency in management, at a variety of forums and conferences in USA, Europe, Asia and Middle East.

Amy Berk MSN, RN is a dedicated, results oriented Healthcare Executive; experienced in program directorship of large, complex healthcare programs and initiatives including the design and implementation of clinical transformation related programs including Population Health Management; Care Management, Utilization Management, Transitions of Care; Clinical / Operational Performance Improvement, Value Based Care Initiatives; ACOs; and Clinical Informatics. She is a self-starter and continues with initiatives and a thought leadership agenda focused on Population Health Management (Care Management / Utilization Management) and care delivery innovations; Patient Medical Home Models, Value Based Care, and Social Determinants of Health. Her expertise lies in Population Health; bridging data for optimal clinical outcomes, and the broader framework of optimizing care delivery and clinical transformation. Prior to Microsoft, Amy served as Director Care Management / Population Health at Tufts Health Plan. Amy's 26 years of healthcare experience also includes strategic, operational and policy consulting on a global level; having worked for IBM, Accenture and Optum spanning notable, innovative projects, e.g.: US (Office of National Coordinator and Military Health Affairs), Germany (with the US DoD), France (APHP), Czech Rep. (Ministry of Health), India (Max Healthcare), Switzerland (Ministry of Health), Abu Dhabi (Cleveland Clinic Abu Dhabi), and Qatar (Supreme Council of Health), and the Republic of South Korea (Ministry of Health). Amy also has experience as a Registered Nurse (CVICU / Cardiology) for 10 years, and as a Master's prepared Advanced Practice Nurse has extensive Management Healthcare Consulting experience.

Gerardo Guillen is currently Biomedical Research Director at the Center for Genetic Engineering and Biotechnology (CIGB) in Havana. He received his Bachelor in Science degree in Chemistry and his Master in Chemistry in 1986 in Odessa University I.I. Mechnikov, and his PhD degree in Biological Sciences in 1995 from Havana University. He joined the CIGB in 1986. For more than twenty five years, he was supervisor of several projects related to prophylactic and therapeutic vaccine developments on hepatitis, dengue, meningitis, pertussis, cancer and COVID as well as drug development against infectious diseases, cancer, cardio protection, neuro protection and wound healing. Dr. Guillen is a Senior Researcher at CIGB, Full Professor at the Havana University and Latinoamerican School of Medicine, Distinguished Professor-at-Large at the University of Science and Technology of China and Member of the Cuban Academy of Science since 2012. He is also member of several scientific societies, editorial boards and advisory committees. He has published 212 scientific papers and held 56 patents. He has been honored with 52 National Awards from the Cuban Academy of Science, the Third World Academy of Science award on Biology, the Annual Award of the Cuban Chemistry Society, the Carlos J. Finlay Medal granted by the Cuban State Council, and the patent award of the World Office of Intellectual Property.

Mrs Shahbarat graduated from the Technion - Israel institute of Technology -Medical Laboratory Sciences(B.Sc), and holds a master's degree in research from the Faculty of special welfare and health science, School of public health University of Haifa. Mrs Shahbarat specializes in, among other, Molecular biology and Molecular genetics. Also, Mrs Shahbarat plays an important role in the establishment and conductingseveral advanced genetic methods of Next-Generation-Sequencing (NGS)and deals mainly with research in the field of embryonic and genetic mutations.

Baig, MMFA is a registered Pharmacist and did a PhD in Chemistry. His recent research interest is designing nanomaterials for Biomedical Engineering, Mechano Pharmacology, Developmental Biology, Structural Biology, and Neuroscience. He got his post-doctoral training in Nanomedicine at the Faculty of Dentistry, The University of Hong Kong. His postdoctoral work was focused on designing DNA-based functional & bio-active nanomaterials to apply in Restorative Dentistry, Oral Microbiology/ Oncology,Regenerative Therapeutics, Stem Cells Research, Drug Delivery, and Molecular Pharmaceutics. He got a Ph.D. degree in Chemistry (Therapeutical Biochemistry) from the School of Chemistry and Chemical Engineering, Nanjing University (NJU), China. During his Ph.D., he worked on DNA Nanotechnology, Nano-Therapeutics, Biosensing, Bio-imaging, Diagnostics, and Cellular Biophysics. Previously, He received his Doctor of Pharmacy (PharmD) and MPhil (Pharmaceutical Chemistry) degrees from the Faculty of Pharmacy, Bahauddin Zakariya University (BZU), Multan, Pakistan; where he learned about Biochemistry, Phytochemistry, Pharmacognosy, Biotechnology, Polymers, Organic, Medicinal, Bio-analytical, and Material Chemistry. His research work mainly focused on the construction and function of DNA nanomachines, which are cuttingedge and challenging topics. He designed and constructed unique DNA molecular tension probes using a short circular DNA nanotechnology technique and functionalized these probes with fluorophores, gold nanoparticles, small molecular drugs, and peptide ligands. He achieved nano-specific precision in organizing plasmonic nanoparticles on the nano DNAframeworks to achieve plasmon resonance effects. My work on the DNA nanomachines provided an efficient mechanism of fluorescence resonance energy transfer that realizes the bio-imaging, anddetection of biological events, and functions of the biomolecules.

Prof. Dr.Surya Bahadur Karki dedicated on yoga & Naturopathy science 2034 Bs, ( 1977Ad) being a Nature Cure physician after popularity around Nationally and a broad, got full recognized from His Majesty Government of Nepal after long Devotion & hard exercise. He established Shanti Devi Nature Cure ashram, Bhadrapur, Jhapa on 2034. Nepal Yoga and Nature Cure Association, at Biratnager on 2040 Bs."Nature Cure Research & Teaching Hospital "at Kathmandu Kalimati on 2053. Institute of Natural Medicine at Kathmandu on 2056 Bs. to continue the said purpose ahead. Dr.Karki prepared the curriculum & the course book for Lower Secondary school and secondary level Collaboration with Curriculum Department of Nepal government.

Will be updated soon

David J. Eaton received his Ph.D. in environmental engineering and geography from Johns Hopkins University. He teaches courses on systems analysis, environmental and energy policy and nonprofit management at the LBJ School of Public Affairs. He has lectured in 20 countries and conducted field research in 15 nations. Eaton has written about rural water supply, international water resource conflicts, energy management, environmental problems of industries, management of emergency medical services, applications of mathematical programming to resource problems, insurance and agriculture. His research focuses on sustainable development in international river basins, evaluation of energy and water conservation programs and prevention of pollution. Among his publications are the NAFTA Handbook for Water Resource Managers and Engineers, "Emergency Medical Services in Travis County, Texas" and "The Impacts of Trade Agreements on State Provincial Laws." Eaton's current research concerns U.S.-Mexico environmental cooperation, new methods for evaluation of air pollution emissions, joint management by Palestinians and Israelis of shared groundwater, and water conservation in Texas. The Texas Department of Insurance used research on tort reform directed by Eaton as evidence to justify rebates of more than $1.3 billion for liability insurance in Texas in 1997-1999

Scott has been president and CEO of four hospitals in three states and has deep industry experience and a national reputation in governance. His focus is centered on clarifying strategy, rapid-deployment culture change and enhanced operational/financial outcomes. Scott is an expert in accelerated operations improvement, encompassing revenue enhancement strategies, improved cash flow, operating cost reduction and action-oriented strategic assessment options. A nationally recognized speaker, Scott has authored and delivered over 500 presentations to various professional associations and healthcare organizations. Scott's most recent book is titled "Community Stewardship: Applying the Five Principles of Contemporary Governance," published by American Hospital Publishing; he is currently researching a third book. He has written two recent articles on population health and reducing waste using comparative analytics. Scott completed his doctorate in Health Administration and Leadership from the Medical University of South Carolina in 2003. He received his master's degree in Hospital Administration from the University of Minnesota, where he was recognized for his academic achievement, and graduated Magna Cum Laude with his bachelor's degree from Ithaca College.

Dr. Maryam Karimi, is an Assistant Professor at UAB School of Public Health, Department of Environmental Health Sciences. She has a joint appointment with School of Civil, Construction and Environmental Engineering. She has diverse set of experiences in environmental science, public health, and urban resiliency, which places her in a unique position for independent research projects aimed towards sustainable cities and human health focusing on developing strategies to counteract climate change at a local and national scale. Her research interests include identifying environmental risk and social vulnerability associated with the impact of Urban Heat Island (UHI) and climate change caused by urban development and air pollution, understanding the structure of cities, urbanization and the role of urban morphology in changing urban microclimate and urban health, urban redesign and building sustainable cities at local and global level, and application of big data and sensing in developing models that predict environmental risk and social vulnerability associated with urban development (UHI), air pollution and population at risk. Her research work has been funded by NIH, NASA and NOAA.

Will be updated Soon

Saffron Karlsen's work aims to enable a better understanding of the different ways in which ethnicity has meaning and relevance in people's lives, both for developing awareness of potential group affiliations and as a driver of health and other inequalities. My research was instrumental in establishing empirical evidence regarding the role of racism in the development of ethnic inequalities in health in the UK. My work has also explored the nature and drivers of ethnic and religious inequalities in the US, New Zealand, Kenya, India, Vietnam, Nigeria and elsewhere in the Global North and South. My work is motivated by the need for the more effective engagement of marginalised groups in the co-production of research, policy and practice, locally, nationally and globally. I have long-standing collaborations with the Race Equality Foundation and Black South West Network. I currently co-lead, with Black South West Network, the Bristol Race Equality Network, which aims to connect research and data to community-led approaches, in ways that recognise, value and respond to communitie's lived experiences and diverse forms of knowledge and expertise, through partnership, collaboration and co-production between academics, community groups and policy-makers. I also work in partnership with community partners and others to draw attention to the problems of FGM-safeguarding policy in the UK and elsewhere. I have acted as an advisor to the Scottish Executive, Cabinet Office and New Zealand Health Department and has worked with the WHO and UN. Recent work on ethnic inequalities in experiences of covid-19 in collaboration with the British Academy has been referenced by SAGE. I am currently a member of the Inclusive Data Taskforce for the UK Statistics Authority. Prior to taking up this post, I was a senior research fellow in the Department of Epidemiology and Public Health at UCL.

Maria Dalamagka currently works at the Department of Anesthesia, General University Hospital of Larissa. Maria does research in acupuncture and Anaesthetics. She is PhD medicine , doctor of pain , MD. Editorial board member :Scifed Journal, Pain Medicine and Management, Enliven, Cient Periodique, Journal of Pain Management and Medicine _Longdom, Anesthesia &Pain Research _Scivision, GJNFS, Journal if Pain and Relief. Speaker and organizing committee to conferences as:Pain Research and Management Zurich 2018, 5th international conference Pain Research &Management London 2017, and Vancouver , Canada 2016, Word congress on Pain Medicine and Management Singapore 2019, International Conference on Alzheimers &Neurodegenerative desease Madrid , Spain 2018, scientific federation speaker

Will be updated soon

Ivan V. Maksimovich, MD,ISTAART member, Head Physician of Clinic of Cardiovascular Diseases named after Most Holy John Tobolsky (Moscow, Russia) since 1993. One of the major problems the clinic deals with is the diagnosis and treatment of various brain lesions including Alzheimer's disease. For a long time I have fully concerned myself with the diagnosis and treatment of Alzheimer's disease. Over the past 15 years I have published over 60 scientific works on this subject.

Professor Xuewu ZHANG, from Changsha, Hunan Province, China, received a bachelor's degree in Mathematics from Hunan Normal University in 1983, a master's degree in Biology from Sun Yat- sen University in 1990 and a doctor's degree in Biology from Sun Yat -sen University in 1993. After graduation, he stayed in the food engineering research center of Sun Yat- sen University. From 1998 to 2003, he successively did postdoctoral research in the University of Hong Kong, the University of British Columbia in Canada, the University of Manitoba in Canada, the University of California at Los Angeles of the United States; From 2003 to 2005, as a winner of the overseas talent introduction program of the Hong Kong government, he served as a research assistant professor at the University of Hong Kong. He joined South China University of Technology as a professor in 2005. With excellent multi-disciplinary background, he is mainly engaged in the research of natural product separation, biological enzymatic hydrolysis, food nutrition, omics technologies and intestinal microbiota, focusing on bioactive peptides and polysaccharides, such as the research on the immunomodulatory activity and intestinal flora of lentinan, and the anti-inflammatory activity of Poria cocos polysaccharide, Seaweed (Spirulina, Chlorella, laver) functional peptides (anti-tumor peptide, anti obesity peptide, anti-aging peptide, hypoglycemic peptide, hypolipidemic peptide, anti-inflammatory peptide, etc.), Dendrobium officinale antitumor peptide, Tilapia skin collagen peptide, Dark tea hypoglycemic peptide, antihypertensive hydrolysates from squid processing by-product, hairtail antidepressant peptide, etc. Since joining South China University of technology in 2005, he has published more than 100 Science-citation-indexed papers, edited one English Monograph (published by Landers bioscience in the United States), participated in the compilation of three English Monographs (published by Taylor & Francis, Springer, Wiley Blackwell), and authorized 32 invention patents. He has been invited to give oral reports at international academic conferences for many times. Now he is the deputy Editor- in- chief of Modern Food Science and Technology.

Dr. Naveen V, PhD, is a Research Fellow at Monash Biomedicine Discovery Institute and Department of Biochemistry of Monash University. He received his Ph.D in the field of Biochemistry, Structural and Molecular Cell Biology from Academia Sinica and National Defence Medical Center in Taiwan. His Master's (M.S and M.phil) in the area of Microbiology was received from Gulbarga University and Periyar University in collaboration with Indian Institute of Science (IISc) (India). He also has robust Biotech industry experience from MerckMillpore as R&D researcher and production in-charge for Microbial Molecular research. Currently, his research is focused on understanding the structural and functional aspects of viruses (including COVID19). He also received several awards and prizes in academic and industrial research.

Pranee is a medical anthropologist and has interests in the health of women, children, immigrants, refugees, older people, and transgender individuals. In terms of health issues, Pranee is very interested in issues relating to motherhood, reproductive health, sexuality, sexual health, and mental health. She has carried out a number of research projects with refugee and immigrant women in Australia and women in Southeast Asia, particularly in Thailand and Malaysia. She has also undertaken qualitative research with women living with HIV/AIDS and women living with breast cancer in Thailand. Pranee's research interest also includes online research and has carried out research in the area of online dating and implications for sexual health. Recently, Pranee has focused her research on sexuality and sexual health issues of Asian women, refugee/immigrant women, young people, and trans women from CALD backgrounds. Pranee has been supervising a large number of research students, both local and international, who have their interests in conducting qualitative research in the areas of gender, sexuality, reproductive health, sexual health and cross-cultural research. Pranee is a qualitative researcher and has written a number of textbooks on this approach. She has written a nunber of textbooks on health-related issues. Some of her textbooks (Qualitative Research Methods, Research Methods in Health: Foundations for Evidence-Based Practice, Social Determinants of Health & Public Health) have been adopted widely, both in Australia and overseas. Her recent work focuses more on the production of handbook, including Handbook of Research Methods in Health Social Sciences and Handbook of Social Inclusion, Research and Practices in the Health and Social Sciences. She has been teaching qualitative research methodology and the social determinants of health units within the postgraduate programs; gender & health; culture, diversity & health; communication in health within the undergraduate programs.

Ming-Chung Jiang, CEO, TargeTrust BIOTECH, Taiwan. Ph.D., Institute of Biochemistry, College of Medicine, National Taiwan University, Taiwan. Medical Researcher, Taipei Medical University Hospital, Taiwan. Dr. Jiang studied tumor biology for 25 years. He has 7 years of clinical medicine experiences in hospital, and 6 years of biomedical product development and verification and company operation management training experiences. He published more than 40 SCI international medical papers mainly the corresponding author. He is the inventor of 3 international patents in more than 10 countries. The product patent is the result of 20 years of research. By the world's first invention "Tumor Signal Transduction-Liquid Biopsy" to assay tumor signal transduction activity in blood, Dr. Jiang invented the world’s only method that can detect cancer therapy resistance in real-time. The method is also the world's only method that can guide optimal drug dose in real-time to reduce side-effects or enhance therapy efficacy in cancer therapy.

Demet is an urban planner and designer and currently a Research Associate at Lancaster University. In all research projects Demet has hitherto worked on, she has mainly aimed to understand the relationship between the built environment and people’s behaviour. Her PhD research aimed to understand how the spatial layouts, particularly landmarks, affect people’s navigational performance and what makes it easier or more challenging for people to find their way. In this research, Demet examined a game, Sea Hero Quest (SHQ), which was developed to understand Alzheimer’s and was played by more than 4.3 million people around the world. She used ArcMap and Depthmap software to analyse spatial layout of game environments, analysed people’s navigation performance and conducted quantitative and qualitative surveys to understand people’s evaluation of landmarks. She worked as a research assistant (RA) on two externally-funded research projects in Turkey and on one REF Impact Case Study in the UK. One of these research projects, “Measuring the Relationship Between Spatial Configuration and User Behaviour: User-Oriented Approaches to Urban Square Design Process at the Peripheral Municipalities of Istanbul”, focused on urban squares designed in the peripheral districts of Istanbul, which act as subcenters, to identify the relationship between spatial configuration and user behaviour. The second research project she has worked on, namely “Preventing Obesity through Walkable Environments: Walking to Elementary Schools”, examined the association of perceived and objectively measured environmental factors with active commuting to school, and considered the impacts of this association on the prevalence of obesity among school children. As part of ICS for REF2021, on the other hand, she explored the social and economic impacts of SHQ by searching for evidence of the wider impacts of the game. Demet’s research interests include Geographic Information Systems (GIS), Space Syntax, spatial analysis, walkability, urban form modelling and human wellbeing.

Dr. Rajib Mondal has received his postgraduate master degree 'Master of Public Health in Noncommunicable Diseases (MPH in NCD)' from Bangladesh University of Health Sciences. Currently, he is working as a Lecturer in the Department of Public Health, Hamdard University Bangladesh. He is a very young early career public health professional exercising in the field of NCDs, the major public health concern in this current world. He does research in the epidemiological aspects of NCDs including their risk factors emphasizing on the exploratory, interventional, and rehabilitative approaches. His area of research interest is in designing the pragmatic preventive strategies in order to reduce the growing epidemic disease burden, including premature deaths. He aims at contributing efficiently to the field of public health in the national, regional and global perspectives.

A practicing physician in the field of healthcare in the state of Kerala in India for the last 32 years and very much interested in basic research. My interest is spread across the fever, inflammation and back pain. I am a writer. I already printed and published nine books on these subjects. I wrote hundreds of articles in various magazines. After scientific studies, we have developed 8000 affirmative cross checking questions. It can explain all queries related to fever.